Ask OpenScientist

Ask a research question about Retrograde Cricopharyngeus Dysfunction. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

2
Pathophys.
5
Phenotypes
1
Treatments
1
Differentials
11
References
2
Deep Research

Pathophysiology

2
Failure of Upper Esophageal Sphincter Relaxation
The cricopharyngeus muscle, which constitutes the upper esophageal sphincter, fails to relax in response to retrograde esophageal gaseous distension that normally triggers belching. This is a reflex-specific deficit, as deglutitive (swallowing-related) UES relaxation remains intact.
muscle cell link ⚠ ABNORMAL sensory neuron link ⚠ ABNORMAL
regulation of muscle contraction link ⚠ ABNORMAL skeletal muscle contraction link ⚠ ABNORMAL
upper esophageal sphincter link cricopharyngeus muscle link
Show evidence (4 references)
PMID:35122356 SUPPORT
"prior to 2019, there were only three case reports in the world literature of individuals with a physiologically demonstrated inability to belch due to failure of the UES to relax after gas venting from the stomach and ensuing low-pressure esophageal distention"
The Kahrilas 2022 review establishes that UES relaxation failure during retrograde gas events is the core pathophysiological mechanism.
PMID:38587015 SUPPORT
"RCPD is associated with a longer UES, elevated UES basal pressures, and an increased incidence of ineffective esophageal motility."
The Yousef 2024 case-control study demonstrated physiological abnormalities in UES function in R-CPD patients.
PMID:41506952 SUPPORT
"high-resolution manometry was performed on both patients, showing elevated basal upper esophageal sphincter (UES) pressure and absence of UES relaxation with attempted belching."
The Dealino 2026 cases document absent UES relaxation during attempted belching.
+ 1 more reference
Elevated Upper Esophageal Sphincter Basal Pressure
Patients with R-CPD have significantly higher resting UES pressure compared to healthy controls, contributing to the inability to release trapped gas.
muscle cell link ⚠ ABNORMAL
muscle contraction link ↑ INCREASED
upper esophageal sphincter link
Show evidence (2 references)
PMID:38587015 SUPPORT
"The RCPD cohort, compared to the asymptomatic cohort, exhibited significantly greater upper esophageal sphincter (UES) length [4.5 (SD: 0.7) vs 3.7 (0.9) cm"
The case-control study quantified higher UES basal pressures in R-CPD patients relative to controls.
PMID:41506952 SUPPORT
"high-resolution manometry was performed on both patients, showing elevated basal upper esophageal sphincter (UES) pressure and absence of UES relaxation with attempted belching."
Elevated resting UES pressure was observed in both cases in the 2026 report.

Phenotypes

5
Digestive 4
Inability to Belch Common Abnormality of the digestive system (HP:0025031)
Show evidence (5 references)
PMID:31236539 SUPPORT
"To propose and test the validity of a new syndrome called retrograde cricopharyngeus dysfunction (R-CPD) that explains inability to belch and the associated symptoms of loud gurgling noises, chest and abdominal pain/distention, and excessive flatulence"
This landmark paper defined R-CPD and established inability to belch as the cardinal feature.
PMID:37621856 SUPPORT
"A large constellation of hitherto unexplained symptoms including inability to burp, gurgling noises from the chest and lower neck, abdominal bloating, flatulence, painful hiccups and emetophobia was defined as Retrograde Cricopharyngeus Dysfunction (R-CPD) in 2019."
The Pavesi 2023 case report reiterates inability to burp as the defining symptom of R-CPD.
PMID:38767031 SUPPORT
"The incapacity to belch is the hallmark of the disease."
The Jiménez-Castillo 2025 series states the hallmark symptom is inability to belch.
+ 2 more references
Abdominal Distention Common Abdominal distention (HP:0003270)
Show evidence (3 references)
PMID:35122356 SUPPORT
"The associated symptom complex includes some combination of chest pain, gurgling noises in the chest, bloating, nausea, hiccups, and flatulence."
Bloating (abdominal distention) is described as part of the core symptom complex of R-CPD.
PMID:37621856 SUPPORT
"A large constellation of hitherto unexplained symptoms including inability to burp, gurgling noises from the chest and lower neck, abdominal bloating, flatulence, painful hiccups and emetophobia was defined as Retrograde Cricopharyngeus Dysfunction (R-CPD) in 2019."
The Pavesi 2023 case report lists abdominal bloating as a key symptom.
PMID:38115814 SUPPORT
"99% reported inability to burp, 98% reported abdominal bloating, 93% reported socially awkward gurgling noises, 89% reported excessive flatulence."
Community survey data show abdominal bloating affects nearly all respondents with R-CPD.
Nausea Variable Nausea (HP:0002018)
Show evidence (1 reference)
PMID:35122356 SUPPORT
"The associated symptom complex includes some combination of chest pain, gurgling noises in the chest, bloating, nausea, hiccups, and flatulence."
Nausea is described as part of the symptom complex associated with R-CPD.
Gurgling Sounds Common Abnormality of the digestive system (HP:0025031)
Show evidence (3 references)
PMID:31236539 SUPPORT
"To propose and test the validity of a new syndrome called retrograde cricopharyngeus dysfunction (R-CPD) that explains inability to belch and the associated symptoms of loud gurgling noises, chest and abdominal pain/distention, and excessive flatulence"
Loud gurgling noises are described as a core feature of R-CPD.
PMID:37621856 SUPPORT
"A large constellation of hitherto unexplained symptoms including inability to burp, gurgling noises from the chest and lower neck, abdominal bloating, flatulence, painful hiccups and emetophobia was defined as Retrograde Cricopharyngeus Dysfunction (R-CPD) in 2019."
Gurgling noises from the chest and lower neck are highlighted among the presenting symptoms.
PMID:38115814 SUPPORT
"99% reported inability to burp, 98% reported abdominal bloating, 93% reported socially awkward gurgling noises, 89% reported excessive flatulence."
Survey responses show gurgling noises are frequent in R-CPD.
Constitutional 1
Chest Pain Common Chest pain (HP:0100749)
Show evidence (1 reference)
PMID:35122356 SUPPORT
"The associated symptom complex includes some combination of chest pain, gurgling noises in the chest, bloating, nausea, hiccups, and flatulence."
Chest pain is identified as a core symptom of retrograde UES dysfunction.
💊

Treatments

1
Botulinum Toxin Injection
Action: botulinum toxin type A therapy MAXO:0009016
Injection of botulinum toxin type A into the cricopharyngeus muscle to induce temporary relaxation. This is both diagnostic and therapeutic, with high success rates in restoring the ability to belch.
Show evidence (8 references)
PMID:31236539 SUPPORT
"All 51 patients achieved ability to belch and relief of associated symptoms, and the majority seem to have "retrained" the ability to belch on a potentially "permanent" basis."
The Bastian 2019 case series demonstrated 100% success rate with botulinum toxin injection in restoring belching ability.
PMID:38587015 SUPPORT
"All patients who underwent cricopharyngeal botulinum injections experienced initial improvement of symptoms with 3 patients requiring repeat intervention."
The Yousef 2024 study confirms botulinum toxin as an effective treatment.
PMID:37621856 SUPPORT
"successfully treated with unilateral, anesthesia-free injection of 10 units of onabotulinum toxin into the cricopharyngeus muscle, representing the lowest dose reported to date."
The Pavesi 2023 case report demonstrates symptom resolution with low-dose botulinum toxin.
+ 5 more references
🔀

Differential Diagnoses

1

Conditions with similar clinical presentations that must be differentiated from Retrograde Cricopharyngeus Dysfunction:

Supragastric Belching
Overlapping Features Functional belching disorder characterized by repetitive supradiaphragmatic air influx and frequent belches, rather than an inability to vent esophageal gas.
Distinguishing Features
  • Patients exhibit frequent, often repetitive belching episodes instead of inability to belch.
  • High-resolution manometry shows normal UES relaxation during belches, without trapped gas-related pressure build-up.
Show evidence (1 reference)
PMID:38767031 SUPPORT
"The incapacity to belch is the hallmark of the disease."
R-CPD is defined by inability to belch, distinguishing it from conditions like supragastric belching where belching is frequent.
{ }

Source YAML

click to show
name: Retrograde Cricopharyngeus Dysfunction
creation_date: '2026-01-10T00:29:46Z'
updated_date: '2026-02-17T21:53:14Z'
description: A syndrome characterized by the inability to belch due to failure
  of the upper esophageal sphincter (cricopharyngeus muscle) to relax in
  response to retrograde esophageal gaseous distension. The associated symptom
  complex includes abdominal bloating, chest pain, gurgling noises in the chest,
  nausea, and excessive flatulence.
category: Syndromic
parents:
- Neuromuscular Disorder
- Gastrointestinal Disorder

disease_term:
  preferred_term: retrograde cricopharyngeus dysfunction
  term:
    id: MONDO:0100099
    label: retrograde cricopharyngeus dysfunction

phenotypes:
- name: Inability to Belch
  description: Complete or near-complete inability to belch (eructate), which is
    the cardinal feature of R-CPD. Patients cannot voluntarily or reflexively
    release gas from the esophagus through the pharynx.
  frequency: Common
  phenotype_term:
    preferred_term: Abnormality of the digestive system
    term:
      id: HP:0025031
      label: Abnormality of the digestive system
  evidence:
  - reference: PMID:31236539
    reference_title: "Inability to Belch and Associated Symptoms Due to Retrograde Cricopharyngeus Dysfunction: Diagnosis and Treatment."
    supports: SUPPORT
    snippet: "To propose and test the validity of a new syndrome called retrograde
      cricopharyngeus dysfunction (R-CPD) that explains inability to belch and the
      associated symptoms of loud gurgling noises, chest and abdominal pain/distention,
      and excessive flatulence"
    explanation: This landmark paper defined R-CPD and established inability to
      belch as the cardinal feature.
  - reference: PMID:37621856
    reference_title: "Retrograde Cricopharyngeus Dysfunction effectively treated with low dose botulinum toxin. A case report from Italy."
    supports: SUPPORT
    snippet: "A large constellation of hitherto unexplained symptoms including inability
      to burp, gurgling noises from the chest and lower neck, abdominal bloating,
      flatulence, painful hiccups and emetophobia was defined as Retrograde Cricopharyngeus
      Dysfunction (R-CPD) in 2019."
    explanation: The Pavesi 2023 case report reiterates inability to burp as the
      defining symptom of R-CPD.
  - reference: PMID:38767031
    reference_title: "The inability to belch - A neglected disease in the era of high-resolution esophageal manometry."
    supports: SUPPORT
    snippet: "The incapacity to belch is the hallmark of the disease."
    explanation: The Jiménez-Castillo 2025 series states the hallmark symptom is
      inability to belch.
  - reference: PMID:36054518
    reference_title: "Retrograde Cricopharyngeus Dysfunction: The Jefferson Experience."
    supports: SUPPORT
    snippet: "The inability to burp (98.8%), bloating (92.9%), gurgling noises (31.8%),
      and excessive flatulence (21.2%) were the most common symptoms."
    explanation: The Jefferson case series quantifies inability to burp as the
      dominant presenting symptom.
  - reference: PMID:38115814
    reference_title: "Retrograde cricopharyngeus dysfunction: How does the inability to burp affect daily life?"
    supports: SUPPORT
    snippet: "99% reported inability to burp, 98% reported abdominal bloating, 93%
      reported socially awkward gurgling noises, 89% reported excessive flatulence."
    explanation: Survey data reinforce inability to burp as near-universal among
      affected patients.
- name: Abdominal Distention
  description: Abdominal bloating and distension due to trapped air that cannot
    be expelled through belching.
  frequency: Common
  phenotype_term:
    preferred_term: Abdominal distention
    term:
      id: HP:0003270
      label: Abdominal distention
  evidence:
  - reference: PMID:35122356
    reference_title: "Retrograde upper esophageal sphincter function… and dysfunction."
    supports: SUPPORT
    snippet: "The associated symptom complex includes some combination of chest pain,
      gurgling noises in the chest, bloating, nausea, hiccups, and flatulence."
    explanation: Bloating (abdominal distention) is described as part of the
      core symptom complex of R-CPD.
  - reference: PMID:37621856
    reference_title: "Retrograde Cricopharyngeus Dysfunction effectively treated with low dose botulinum toxin. A case report from Italy."
    supports: SUPPORT
    snippet: "A large constellation of hitherto unexplained symptoms including inability
      to burp, gurgling noises from the chest and lower neck, abdominal bloating,
      flatulence, painful hiccups and emetophobia was defined as Retrograde Cricopharyngeus
      Dysfunction (R-CPD) in 2019."
    explanation: The Pavesi 2023 case report lists abdominal bloating as a key
      symptom.
  - reference: PMID:38115814
    reference_title: "Retrograde cricopharyngeus dysfunction: How does the inability to burp affect daily life?"
    supports: SUPPORT
    snippet: "99% reported inability to burp, 98% reported abdominal bloating, 93%
      reported socially awkward gurgling noises, 89% reported excessive flatulence."
    explanation: Community survey data show abdominal bloating affects nearly
      all respondents with R-CPD.
- name: Chest Pain
  description: Chest discomfort or pain, particularly after eating, related to
    air entrapment in the esophagus.
  frequency: Common
  phenotype_term:
    preferred_term: Chest pain
    term:
      id: HP:0100749
      label: Chest pain
  evidence:
  - reference: PMID:35122356
    reference_title: "Retrograde upper esophageal sphincter function… and dysfunction."
    supports: SUPPORT
    snippet: "The associated symptom complex includes some combination of chest pain,
      gurgling noises in the chest, bloating, nausea, hiccups, and flatulence."
    explanation: Chest pain is identified as a core symptom of retrograde UES
      dysfunction.
- name: Nausea
  description: Nausea, often occurring after meals due to air entrapment and
    inability to release gastric gas.
  frequency: Variable
  phenotype_term:
    preferred_term: Nausea
    term:
      id: HP:0002018
      label: Nausea
  evidence:
  - reference: PMID:35122356
    reference_title: "Retrograde upper esophageal sphincter function… and dysfunction."
    supports: SUPPORT
    snippet: "The associated symptom complex includes some combination of chest pain,
      gurgling noises in the chest, bloating, nausea, hiccups, and flatulence."
    explanation: Nausea is described as part of the symptom complex associated
      with R-CPD.
- name: Gurgling Sounds
  description: Socially awkward gurgling noises from the chest and lower neck as
    the esophagus churns attempting to expel trapped air.
  frequency: Common
  phenotype_term:
    preferred_term: Abnormality of the digestive system
    term:
      id: HP:0025031
      label: Abnormality of the digestive system
  evidence:
  - reference: PMID:31236539
    reference_title: "Inability to Belch and Associated Symptoms Due to Retrograde Cricopharyngeus Dysfunction: Diagnosis and Treatment."
    supports: SUPPORT
    snippet: "To propose and test the validity of a new syndrome called retrograde
      cricopharyngeus dysfunction (R-CPD) that explains inability to belch and the
      associated symptoms of loud gurgling noises, chest and abdominal pain/distention,
      and excessive flatulence"
    explanation: Loud gurgling noises are described as a core feature of R-CPD.
  - reference: PMID:37621856
    reference_title: "Retrograde Cricopharyngeus Dysfunction effectively treated with low dose botulinum toxin. A case report from Italy."
    supports: SUPPORT
    snippet: "A large constellation of hitherto unexplained symptoms including inability
      to burp, gurgling noises from the chest and lower neck, abdominal bloating,
      flatulence, painful hiccups and emetophobia was defined as Retrograde Cricopharyngeus
      Dysfunction (R-CPD) in 2019."
    explanation: Gurgling noises from the chest and lower neck are highlighted
      among the presenting symptoms.
  - reference: PMID:38115814
    reference_title: "Retrograde cricopharyngeus dysfunction: How does the inability to burp affect daily life?"
    supports: SUPPORT
    snippet: "99% reported inability to burp, 98% reported abdominal bloating, 93%
      reported socially awkward gurgling noises, 89% reported excessive flatulence."
    explanation: Survey responses show gurgling noises are frequent in R-CPD.

pathophysiology:
- name: Failure of Upper Esophageal Sphincter Relaxation
  description: The cricopharyngeus muscle, which constitutes the upper
    esophageal sphincter, fails to relax in response to retrograde esophageal
    gaseous distension that normally triggers belching. This is a
    reflex-specific deficit, as deglutitive (swallowing-related) UES relaxation
    remains intact.
  cell_types:
  - preferred_term: muscle cell
    modifier: ABNORMAL
    term:
      id: CL:0000187
      label: muscle cell
  - preferred_term: sensory neuron
    modifier: ABNORMAL
    term:
      id: CL:0000101
      label: sensory neuron
  biological_processes:
  - preferred_term: regulation of muscle contraction
    modifier: ABNORMAL
    term:
      id: GO:0006937
      label: regulation of muscle contraction
  - preferred_term: skeletal muscle contraction
    modifier: ABNORMAL
    term:
      id: GO:0003009
      label: skeletal muscle contraction
  locations:
  - preferred_term: upper esophageal sphincter
    term:
      id: UBERON:0007268
      label: upper esophageal sphincter
  - preferred_term: cricopharyngeus muscle
    term:
      id: UBERON:0010928
      label: cricopharyngeus muscle
  evidence:
  - reference: PMID:35122356
    reference_title: "Retrograde upper esophageal sphincter function… and dysfunction."
    supports: SUPPORT
    snippet: "prior to 2019, there were only three case reports in the world literature
      of individuals with a physiologically demonstrated inability to belch due to
      failure of the UES to relax after gas venting from the stomach and ensuing low-pressure
      esophageal distention"
    explanation: The Kahrilas 2022 review establishes that UES relaxation
      failure during retrograde gas events is the core pathophysiological
      mechanism.
  - reference: PMID:38587015
    reference_title: "Upper Esophageal Sphincter and Esophageal Motility Pathology on Manometry in Retrograde Cricopharyngeal Dysfunction."
    supports: SUPPORT
    snippet: "RCPD is associated with a longer UES, elevated UES basal pressures,
      and an increased incidence of ineffective esophageal motility."
    explanation: The Yousef 2024 case-control study demonstrated physiological
      abnormalities in UES function in R-CPD patients.
  - reference: PMID:41506952
    reference_title: "Retrograde cricopharyngeal dysfunction: Two case reports and a literature review."
    supports: SUPPORT
    snippet: "high-resolution manometry was performed on both patients, showing elevated
      basal upper esophageal sphincter (UES) pressure and absence of UES relaxation
      with attempted belching."
    explanation: The Dealino 2026 cases document absent UES relaxation during
      attempted belching.
  - reference: PMID:38767031
    reference_title: "The inability to belch - A neglected disease in the era of high-resolution esophageal manometry."
    supports: SUPPORT
    snippet: "We performed HRM with a belch provocation test for which the patient
      drank 500 ml of carbonated water. The study revealed increased esophageal pressure,
      an absence of UES relaxation and secondary peristalsis once the patient mentioned
      the need to belch."
    explanation: The Jiménez-Castillo 2025 case series shows failure of UES
      relaxation during retrograde distension.

- name: Elevated Upper Esophageal Sphincter Basal Pressure
  description: Patients with R-CPD have significantly higher resting UES
    pressure compared to healthy controls, contributing to the inability to
    release trapped gas.
  cell_types:
  - preferred_term: muscle cell
    modifier: ABNORMAL
    term:
      id: CL:0000187
      label: muscle cell
  biological_processes:
  - preferred_term: muscle contraction
    modifier: INCREASED
    term:
      id: GO:0006936
      label: muscle contraction
  locations:
  - preferred_term: upper esophageal sphincter
    term:
      id: UBERON:0007268
      label: upper esophageal sphincter
  evidence:
  - reference: PMID:38587015
    reference_title: "Upper Esophageal Sphincter and Esophageal Motility Pathology on Manometry in Retrograde Cricopharyngeal Dysfunction."
    supports: SUPPORT
    snippet: "The RCPD cohort, compared to the asymptomatic cohort, exhibited significantly
      greater upper esophageal sphincter (UES) length [4.5 (SD: 0.7) vs 3.7 (0.9)
      cm"
    explanation: The case-control study quantified higher UES basal pressures in
      R-CPD patients relative to controls.
  - reference: PMID:41506952
    reference_title: "Retrograde cricopharyngeal dysfunction: Two case reports and a literature review."
    supports: SUPPORT
    snippet: "high-resolution manometry was performed on both patients, showing elevated
      basal upper esophageal sphincter (UES) pressure and absence of UES relaxation
      with attempted belching."
    explanation: Elevated resting UES pressure was observed in both cases in the
      2026 report.

treatments:
- name: Botulinum Toxin Injection
  description: Injection of botulinum toxin type A into the cricopharyngeus
    muscle to induce temporary relaxation. This is both diagnostic and
    therapeutic, with high success rates in restoring the ability to belch.
  treatment_term:
    preferred_term: botulinum toxin type A therapy
    term:
      id: MAXO:0009016
      label: botulinum toxin type A therapy
  evidence:
  - reference: PMID:31236539
    reference_title: "Inability to Belch and Associated Symptoms Due to Retrograde Cricopharyngeus Dysfunction: Diagnosis and Treatment."
    supports: SUPPORT
    snippet: "All 51 patients achieved ability to belch and relief of associated symptoms,
      and the majority seem to have \"retrained\" the ability to belch on a potentially
      \"permanent\" basis."
    explanation: The Bastian 2019 case series demonstrated 100% success rate
      with botulinum toxin injection in restoring belching ability.
  - reference: PMID:38587015
    reference_title: "Upper Esophageal Sphincter and Esophageal Motility Pathology on Manometry in Retrograde Cricopharyngeal Dysfunction."
    supports: SUPPORT
    snippet: "All patients who underwent cricopharyngeal botulinum injections experienced
      initial improvement of symptoms with 3 patients requiring repeat intervention."
    explanation: The Yousef 2024 study confirms botulinum toxin as an effective
      treatment.
  - reference: PMID:37621856
    reference_title: "Retrograde Cricopharyngeus Dysfunction effectively treated with low dose botulinum toxin. A case report from Italy."
    supports: SUPPORT
    snippet: "successfully treated with unilateral, anesthesia-free injection of 10
      units of onabotulinum toxin into the cricopharyngeus muscle, representing the
      lowest dose reported to date."
    explanation: The Pavesi 2023 case report demonstrates symptom resolution
      with low-dose botulinum toxin.
  - reference: PMID:41200864
    reference_title: "How I Do It: The Transtracheal Approach for Awake Cricopharyngeal Botulinum Toxin Injection."
    supports: SUPPORT
    snippet: "This transtracheal technique for cricopharyngeal botulinum toxin injection
      is a safe and effective option for chemodenervation of this muscle in the awake
      patient."
    explanation: The Tritter 2025 procedural report supports safety and
      effectiveness of the transtracheal botulinum approach.
  - reference: PMID:41506952
    reference_title: "Retrograde cricopharyngeal dysfunction: Two case reports and a literature review."
    supports: SUPPORT
    snippet: "previously undergone percutaneous botulinum toxin injection that initially
      provided temporary relief."
    explanation: The Dealino 2026 case notes symptomatic improvement after
      botulinum toxin injection.
  - reference: PMID:40411338
    reference_title: "Etiology, Clinical Presentation, and Management of Retrograde Cricopharyngeus Dysfunction: A Systematic Review."
    supports: SUPPORT
    snippet: "The immediate success rate of botulinum toxin injection into the cricopharyngeal
      sphincter in facilitating burping was 92.5%."
    explanation: Systematic review reports high immediate success for botulinum
      toxin in R-CPD.
  - reference: PMID:39883449
    reference_title: "Origin and In-Office Treatment of Retrograde Cricopharyngeus Dysfunction."
    supports: SUPPORT
    snippet: "The cumulative success rate of BTI was 90.6% (96 of 106 patients)."
    explanation: In-office botulinum injections achieved high cumulative success
      in a 106-patient series.
  - reference: PMID:38576368
    reference_title: "Retrograde Cricopharyngeus Dysfunction, a New Motility Disorder: Single Center Case Series and Treatment Results."
    supports: SUPPORT
    snippet: "At median follow-up of 29 months (range, 3-50) post-treatment, 51.3%
      (n = 20/39) of patients reported persistent complete relief of symptoms"
    explanation: Belgian case series quantifies short- and long-term response
      rates to botulinum toxin.

diagnosis:
- name: High-Resolution Impedance Manometry
  description: HRIM with provocative carbonated water challenge can objectively
    demonstrate failure of UES relaxation during gaseous distension, confirming
    the diagnosis.
  evidence:
  - reference: PMID:35122356
    reference_title: "Retrograde upper esophageal sphincter function… and dysfunction."
    supports: SUPPORT
    snippet: "The field has now further advanced with the publication in this issue
      of the Journal by Oude Nijhuis et al. of 8 cases of R-UESD demonstrated by high-resolution
      impedance manometry (HRIM) with a provocative challenge of carbonated water."
    explanation: HRIM with provocative testing provides objective diagnostic
      confirmation of R-CPD.
  - reference: PMID:38587015
    reference_title: "Upper Esophageal Sphincter and Esophageal Motility Pathology on Manometry in Retrograde Cricopharyngeal Dysfunction."
    supports: SUPPORT
    snippet: "Esophageal high-resolution impedance manometry was completed preoperatively
      in patients diagnosed with RCPD."
    explanation: HRIM is used for demonstrating UES abnormalities in R-CPD.
  - reference: PMID:38767031
    reference_title: "The inability to belch - A neglected disease in the era of high-resolution esophageal manometry."
    supports: SUPPORT
    snippet: "We performed HRM with a belch provocation test for which the patient
      drank 500 ml of carbonated water. The study revealed increased esophageal pressure,
      an absence of UES relaxation and secondary peristalsis once the patient mentioned
      the need to belch."
    explanation: HRM with belch provocation shows characteristic pressure rise
      and absent UES relaxation in R-CPD.

differential_diagnoses:
- name: Supragastric Belching
  description: Functional belching disorder characterized by repetitive
    supradiaphragmatic air influx and frequent belches, rather than an inability
    to vent esophageal gas.
  distinguishing_features:
  - Patients exhibit frequent, often repetitive belching episodes instead of
    inability to belch.
  - High-resolution manometry shows normal UES relaxation during belches,
    without trapped gas-related pressure build-up.
  evidence:
  - reference: PMID:38767031
    reference_title: "The inability to belch - A neglected disease in the era of high-resolution esophageal manometry."
    supports: SUPPORT
    snippet: "The incapacity to belch is the hallmark of the disease."
    explanation: R-CPD is defined by inability to belch, distinguishing it from
      conditions like supragastric belching where belching is frequent.

notes: >
  R-CPD was first formally described as a clinical entity in 2019 by Bastian and Smithson.
  Prior to this, only three case reports existed in the literature of individuals
  with
  physiologically demonstrated inability to belch. The condition is now recognized
  as
  more common than previously thought. Many patients retain the ability to belch after
  botulinum toxin treatment beyond the expected pharmacologic duration, suggesting
  reflex reprogramming or central adaptation may occur.
references:
- reference: DOI:10.1002/jpn3.12193
  title: Pediatric retrograde cricopharyngeal dysfunction diagnosed by
    high‐resolution impedance manometry
  findings: []
- reference: DOI:10.1002/ohn.735
  title: Upper Esophageal Sphincter and Esophageal Motility Pathology on
    Manometry in Retrograde Cricopharyngeal Dysfunction
  findings: []
- reference: DOI:10.1002/oto2.70014
  title: 'Diagnosis and Management of Retrograde Cricopharyngeal Dysfunction: A Systematic
    Review'
  findings: []
- reference: DOI:10.1007/s00405-024-08644-7
  title: 'Cricopharyngeus muscle dysfunction: a poorly defined disorder from diagnosis
    to treatment'
  findings: []
- reference: DOI:10.1111/nmo.14328
  title: Retrograde upper esophageal sphincter function… and dysfunction
  findings: []
- reference: DOI:10.1152/ajpgi.00007.2012
  title: The role of the superior laryngeal nerve in esophageal reflexes
  findings: []
- reference: DOI:10.1152/ajpgi.00292.2018
  title: Effects of esophageal acidification on esophageal reflexes controlling
    the upper esophageal sphincter
  findings: []
- reference: DOI:10.1177/19160216251329012
  title: 'Etiology, Clinical Presentation, and Management of Retrograde Cricopharyngeus
    Dysfunction: A Systematic Review'
  findings: []
- reference: DOI:10.1177/2473974x19834553
  title: 'Inability to Belch and Associated Symptoms Due to Retrograde Cricopharyngeus
    Dysfunction: Diagnosis and Treatment'
  findings: []
- reference: DOI:10.1177/2473974x20938342
  title: The Long‐term Efficacy of Botulinum Toxin Injection to Treat Retrograde
    Cricopharyngeus Dysfunction
  findings: []
- reference: DOI:10.3389/fneur.2022.1005655
  title: 'Case report: A case of novel treatment for retrograde cricopharyngeal dysfunction'
  findings: []
📚

References & Deep Research

References

11
Pediatric retrograde cricopharyngeal dysfunction diagnosed by high‐resolution impedance manometry
No top-level findings curated for this source.
Upper Esophageal Sphincter and Esophageal Motility Pathology on Manometry in Retrograde Cricopharyngeal Dysfunction
No top-level findings curated for this source.
Diagnosis and Management of Retrograde Cricopharyngeal Dysfunction: A Systematic Review
No top-level findings curated for this source.
Cricopharyngeus muscle dysfunction: a poorly defined disorder from diagnosis to treatment
No top-level findings curated for this source.
Retrograde upper esophageal sphincter function… and dysfunction
No top-level findings curated for this source.
The role of the superior laryngeal nerve in esophageal reflexes
No top-level findings curated for this source.
Effects of esophageal acidification on esophageal reflexes controlling the upper esophageal sphincter
No top-level findings curated for this source.
Etiology, Clinical Presentation, and Management of Retrograde Cricopharyngeus Dysfunction: A Systematic Review
No top-level findings curated for this source.
Inability to Belch and Associated Symptoms Due to Retrograde Cricopharyngeus Dysfunction: Diagnosis and Treatment
No top-level findings curated for this source.
The Long‐term Efficacy of Botulinum Toxin Injection to Treat Retrograde Cricopharyngeus Dysfunction
No top-level findings curated for this source.
Case report: A case of novel treatment for retrograde cricopharyngeal dysfunction
No top-level findings curated for this source.

Deep Research

2
Disorder

Disorder

  • Name: Retrograde Cricopharyngeus Dysfunction
  • Category: Syndromic
  • Existing deep-research providers: falcon
  • Existing evidence reference count in YAML: 42

Key Pathophysiology Nodes

  • Failure of Upper Esophageal Sphincter Relaxation
  • Elevated Upper Esophageal Sphincter Basal Pressure
  • Deep research literature mapping

Citation Inventory (for evidence mapping)

  • DOI:10.1002/jpn3.12193
  • DOI:10.1002/ohn.735
  • DOI:10.1002/oto2.70014
  • DOI:10.1007/s00405-024-08644-7
  • DOI:10.1111/nmo.14328
  • DOI:10.1152/ajpgi.00007.2012
  • DOI:10.1152/ajpgi.00292.2018
  • DOI:10.1177/19160216251329012
  • DOI:10.1177/2473974x19834553
  • DOI:10.1177/2473974x20938342
  • DOI:10.3389/fneur.2022.1005655
Falcon
Disease Pathophysiology Research Report
Edison Scientific Literature 31 citations 2025-12-16T14:47:22.861792

Disease Pathophysiology Research Report

Target Disease

  • Disease Name: Retrograde Cricopharyngeus Dysfunction (R-CPD)
  • MONDO ID: MONDO:0100099 (if available)
  • Category: Syndromic

Pathophysiology description

Retrograde Cricopharyngeus Dysfunction is characterized by a failure of the upper esophageal sphincter (UES), largely constituted by the cricopharyngeus muscle, to relax in response to retrograde esophageal gaseous distension that normally triggers belching. High-resolution impedance manometry (HRIM) studies with provocative carbonated-water challenges demonstrate common-cavity pressurization from gastric gas reflux without the expected, complete UES relaxation and air venting, resulting in air trapping within the esophagus. Clinically this manifests as inability to belch with associated chest/neck gurgling, bloating, chest discomfort, and excessive flatulence (i.e., the “no-burp” syndrome). Botulinum toxin injection targeting the cricopharyngeus (CP) reproducibly restores belching and relieves symptoms, often with durability that outlasts the pharmacologic window, supporting a neuromuscular reflex-control failure rather than structural obstruction as the core mechanism (kahrilas2022retrogradeupperesophageal pages 1-3, kahrilas2022retrogradeupperesophageal pages 4-6, yousef2024upperesophagealsphincter pages 8-12, xie2022casereporta pages 1-2, krekeler2024cricopharyngeusmuscledysfunction pages 4-6).

Mechanistically, the normal belch sequence involves a transient lower esophageal sphincter relaxation with gas reflux and esophageal pressurization, followed by UES/CP relaxation and esophago-pharyngeal gas venting; HRIM and physiologic experiments indicate the UES relaxation is volume- and pressure-dependent and mediated by vagal and superior laryngeal nerve (SLN) pathways. In R-CPD, this retrograde UES relaxation fails despite preserved deglutitive UES relaxation, i.e., a reflex-specific deficit. This failure diverts gas clearance to secondary peristalsis, producing repeated audible gurgling and symptomatic air trapping (kahrilas2022retrogradeupperesophageal pages 3-4, kahrilas2022retrogradeupperesophageal pages 1-3, xie2022casereporta pages 1-2).

Recent developments and latest research

  • Case-control HRIM (2024) showed R-CPD patients have significantly longer UES length and higher basal UES pressures versus age/sex-matched controls, plus increased ineffective swallows and incomplete bolus clearance, establishing objective physiologic correlates and coexisting esophageal dysmotility in some patients (Yousef et al., Otolaryngology–Head & Neck Surgery, Apr 2024; https://doi.org/10.1002/ohn.735) (yousef2024upperesophagealsphincter pages 8-12).
  • Pediatric HRIM series (2024) described adolescents with normal deglutitive UES relaxation but abnormal UES relaxation with high impedance during carbonated drink challenge, consistent with selective failure of the belch reflex; all improved after CP botulinum injection (Journal of Pediatric Gastroenterology and Nutrition, Mar 2024; https://doi.org/10.1002/jpn3.12193) (xie2022casereporta pages 1-2).
  • Minireview (2022) synthesized evidence that HRIM with provocative testing can objectively demonstrate failure of UES relaxation during gaseous distension and that CP botulinum injection normalizes findings and relieves symptoms (Neurogastroenterology & Motility, Feb 2022; https://doi.org/10.1111/nmo.14328) (kahrilas2022retrogradeupperesophageal pages 1-3, kahrilas2022retrogradeupperesophageal pages 4-6).
  • Systematic reviews (2024–2025) summarize high immediate success rates of CP botulinum toxin and document typical symptom complex, while highlighting heterogeneity and the need for standardized diagnostic criteria and prospective outcomes research (OTO Open, Oct 2024; https://doi.org/10.1002/oto2.70014; Journal of Otolaryngology–Head & Neck Surgery, May 2025; https://doi.org/10.1177/19160216251329012) (krekeler2024cricopharyngeusmuscledysfunction pages 4-6, lechien2025etiologyclinicalpresentation pages 1-3).

Current applications and real-world implementations

  • Diagnostic: HRIM with impedance plus provocative carbonated-water ingestion to elicit esophageal gas pressurization and assess for appropriate UES relaxation; selective failure of retrograde (but not swallow-related) UES relaxation supports R-CPD (yousef2024upperesophagealsphincter pages 8-12, xie2022casereporta pages 1-2, kahrilas2022retrogradeupperesophageal pages 1-3).
  • Therapeutic: EMG/endoscopic/ultrasound-guided botulinum toxin injection into the cricopharyngeus is both diagnostic and therapeutic; durable response in many patients; cricopharyngeal myotomy is a salvage option in recalcitrant cases (kahrilas2022retrogradeupperesophageal pages 4-6, yousef2024upperesophagealsphincter pages 8-12, xie2022casereporta pages 1-2, krekeler2024cricopharyngeusmuscledysfunction pages 4-6).

Expert opinions and analysis from authoritative sources

  • “Failure of the UES to relax during retrograde gastroesophageal gas events (belching) leads to inability to vent esophago‑pharyngeal gas,” with HRIM evidence and response to botulinum toxin arguing for a reflex-control failure centered at the cricopharyngeus (Neurogastroenterology & Motility, 2022) (kahrilas2022retrogradeupperesophageal pages 4-6).
  • Systematic syntheses emphasize that botulinum toxin’s immediate success in enabling belching supports a neuromuscular pathophysiology, while variability in relapse highlights heterogeneity and potential coexisting motility disorders that merit stratified evaluation (2024–2025) (krekeler2024cricopharyngeusmuscledysfunction pages 4-6, lechien2025etiologyclinicalpresentation pages 1-3).

Relevant statistics and data from recent studies

  • Large case series (n=200): 99.5% gained ability to burp after CP botulinum toxin; 95% relieved cardinal symptoms; 79.9% maintained satisfactory belching beyond 6 months after a single injection (OTO Open, Apr 2020; https://doi.org/10.1177/2473974x20938342) (yousef2024upperesophagealsphincter pages 8-12, krekeler2024cricopharyngeusmuscledysfunction pages 4-6).
  • Systematic review (2025): Immediate success rate of botulinum toxin enabling burping 92.5%; transient dysphagia most common adverse event (31.1%); recurrences at >6 months in 27.9% (Journal of Otolaryngology–Head & Neck Surgery, May 2025; https://doi.org/10.1177/19160216251329012) (lechien2025etiologyclinicalpresentation pages 1-3).
  • Systematic review (2024): Across pooled reports, 86.9% improved after initial BTX; common initial dose 50 U; some required repeat injection or myotomy (OTO Open, Oct 2024; https://doi.org/10.1002/oto2.70014) (krekeler2024cricopharyngeusmuscledysfunction pages 4-6).
  • Case-control HRIM (2024): R-CPD vs controls—higher UES basal pressure (e.g., ~92 vs ~50 mmHg), longer UES, higher rates of ineffective swallows and incomplete bolus clearance; all treated patients had initial improvement after CP botulinum injection (Otolaryngology–Head & Neck Surgery, Apr 2024; https://doi.org/10.1002/ohn.735) (yousef2024upperesophagealsphincter pages 8-12).
Study (first author, year) Design / Population Key Physiologic Findings (UES/CP behavior; HRIM metrics) Neural Reflex Insights Treatment Outcomes (botulinum toxin / myotomy) URL (with DOI) Publication date (month/year)
Kahrilas 2022 Minireview / case-series synthesis Failure of UES relaxation to retrograde gas; HRIM with carbonated-water provocation demonstrates absent UES relaxation despite common-cavity events Belch reflex: tLESR → esophageal pressurization → UES relaxation; reflex is pressure- and volume-dependent; complex vagal/SLN mediation (belch vs swallow differences) (kahrilas2022retrogradeupperesophageal pages 1-3) BTX to CPM restores belching in reported series; supports reflex failure rather than fixed obstruction (kahrilas2022retrogradeupperesophageal pages 1-3) https://doi.org/10.1111/nmo.14328 Feb 2022
Yousef 2024 Case-control HRIM study (R-CPD n=13 vs controls n=26) R-CPD: longer UES length and markedly higher UES basal pressures (mean ~92 mmHg vs ~50 mmHg); ↑ ineffective swallows and incomplete bolus clearance on HRIM (yousef2024upperesophagealsphincter pages 8-12) Supports impaired retrograde UES relaxation with concomitant esophageal motility abnormalities; suggests phenotypic heterogeneity (yousef2024upperesophagealsphincter pages 8-12) All treated with CP botulinum had initial improvement; some required repeat injections (yousef2024upperesophagealsphincter pages 8-12) https://doi.org/10.1002/ohn.735 Apr 2024
Dorfman 2024 (pediatric HRIM) Pediatric case series (adolescents with inability to burp) Normal deglutitive UES relaxation but abnormal UES relaxation to carbonated-drink provocation with high impedance indicating air entrapment; several had esophageal motility disorders (xie2022casereporta pages 1-2, yousef2024upperesophagealsphincter pages 8-12) Provocation HRIM shows selective failure of retrograde-triggered UES relaxation; supports reflex-specific dysfunction rather than global swallow failure (xie2022casereporta pages 1-2) Symptom improvement/resolution after BTX into CPM reported in cohort (xie2022casereporta pages 1-2) https://doi.org/10.1002/jpn3.12193 Mar 2024
Bastian 2019 Consecutive case series (n=51) Syndromic diagnostic criteria for R-CPD (inability to belch, gurgling, bloating); BTX injection into CPM produced restoration of burping in all patients; many retained function beyond expected pharmacologic window (kahrilas2022retrogradeupperesophageal pages 4-6) Clinical validation that targeted chemodenervation of CPM unmasks/refutes diagnosis; implies neuromuscular/reflex control locus at CPM (kahrilas2022retrogradeupperesophageal pages 4-6) 100% short-term success with BTX; many maintained long-term retrained belching; few required myotomy (kahrilas2022retrogradeupperesophageal pages 4-6) https://doi.org/10.1177/2473974x19834553 Mar 2019
Hoesli 2020 Large retrospective case series (first 200 patients treated) 99.5% gained ability to burp after BTX; 79.9% maintained satisfactory burping >6 months after single injection; supports durable functional recovery in many (yousef2024upperesophagealsphincter pages 8-12, krekeler2024cricopharyngeusmuscledysfunction pages 4-6) Outcome data implies functional reprogramming of reflex circuits or central adaptation after temporary CPM denervation (yousef2024upperesophagealsphincter pages 8-12) BTX injection safe; minority required repeat injections or partial myotomy (yousef2024upperesophagealsphincter pages 8-12) https://doi.org/10.1177/2473974x20938342 Apr 2020
Xie 2022 Single case report with HRM and guided BTX injection HRM: elevated UES residual pressure (22.6 mmHg; normal <12); imaging showed air trapping; post-BTX residual pressure normalized (5.5 mmHg) with symptom resolution (xie2022casereporta pages 1-2) Objective demonstration of selective failure of retrograde UES relaxation with normalization after targeted CPM chemodenervation (xie2022casereporta pages 1-2) Rapid, complete symptom resolution after BTX (50 U) with sustained effect at follow-up; supports diagnostic/therapeutic role of BTX (xie2022casereporta pages 1-2) https://doi.org/10.3389/fneur.2022.1005655 Dec 2022
Krekeler 2024 (review) Narrative review of CPM dysfunction Summarizes HRIM findings: abnormal retrograde UES relaxation, air entrapment on impedance, possible HRPM-I thresholds (e.g., abnormal relaxation pressure >8 mmHg) (krekeler2024cricopharyngeusmuscledysfunction pages 4-6) Highlights knowledge gaps in reflex circuitry but emphasizes vagal/SLN afferent roles and need for standardized diagnostic criteria (krekeler2024cricopharyngeusmuscledysfunction pages 4-6) Reviews evidence for BTX as first-line; myotomy for refractory cases; calls for prospective trials (krekeler2024cricopharyngeusmuscledysfunction pages 4-6) https://doi.org/10.1007/s00405-024-08644-7 May 2024
Lang 2012 Animal (decerebrate cat) experiments on SLN role Rapid esophageal distension triggers belch sequence with UES (CP) inhibition; distinct receptors (mucosal rapidly adapting vs muscular slowly adapting) evoke different UES responses (lang2012theroleof pages 11-12, lang2012theroleof pages 1-1) SLN afferents mediate CP inhibition component of belch; vagal afferents required for belch initiation; SLN transection abolishes CP inhibition while vagotomy abolishes belch (lang2012theroleof pages 11-12) Mechanistic/physiologic foundation explaining why CPM denervation (BTX) can restore venting by removing hyperactive CP tone (lang2012theroleof pages 11-12) https://doi.org/10.1152/ajpgi.00007.2012 Jun 2012
Lang 2019 Animal studies on esophageal acidification effects Short-term acid sensitizes EURR (esophago-UES relaxation reflex) and desensitizes EUCR; longer exposure inhibits EURR and EUCR—showing plasticity of reflexes (lang2019effectsofesophageal pages 18-23) Demonstrates that peripheral sensitization/desensitization (e.g., acid exposure) alters reflex thresholds controlling UES relaxation/contraction (lang2019effectsofesophageal pages 18-23) Implies reflux or mucosal afferent modulation could influence R-CPD phenotype or severity; therapeutic implications for modulating afferent input (lang2019effectsofesophageal pages 18-23) https://doi.org/10.1152/ajpgi.00292.2018 Jan 2019
Szczesniak 2008 Review of esophageal afferent pathways Describes vagal mechanoreceptors (IGLEs) and mucosal receptors mediating esophago-pharyngeal reflexes; evidence that mucosal anesthesia abolishes certain UES relaxations—underscoring sensory afferent dependence (szczesniak2008…andpathophysiological pages 58-61, szczesniak2008…andpathophysiological pages 88-94) Highlights central afferent processing and pharmacologic modulation (e.g., GABAB effects on afferent traffic) that can block distension-induced UES responses (szczesniak2008…andpathophysiological pages 58-61, szczesniak2008…andpathophysiological pages 88-94) Provides rationale for therapies targeting sensory modulation or central processing in addition to CPM-focused interventions (szczesniak2008…andpathophysiological pages 58-61) (review; DOI varies) 2008

Table: Evidence matrix summarizing key recent studies on Retrograde Cricopharyngeus Dysfunction (R-CPD), their physiologic findings, neural reflex insights, and treatment outcomes; useful for quickly locating mechanistic and clinical citations.

Core Pathophysiology

1) Primary mechanisms - Reflex-specific failure of UES/cricopharyngeus relaxation in response to abrupt proximal esophageal gaseous distension (belch trigger), despite normal deglutitive UES relaxation. This causes air trapping, common-cavity pressurization without pharyngeal venting, and compensatory secondary peristalsis with gurgling (Neurogastroenterology & Motility 2022; Otolaryngology–HNS 2024; J Pediatr Gastroenterol Nutr 2024) (kahrilas2022retrogradeupperesophageal pages 1-3, yousef2024upperesophagealsphincter pages 8-12, xie2022casereporta pages 1-2, kahrilas2022retrogradeupperesophageal pages 3-4). - Elevated basal UES tone/length and frequent ineffective esophageal motility occur in a subset, potentially amplifying air entrapment and symptom severity (Otolaryngology–HNS 2024) (yousef2024upperesophagealsphincter pages 8-12). - Robust clinical and HRIM improvement after targeted CP chemodenervation with botulinum toxin implicates hypertonic CP muscle and/or aberrant reflex control as the operative defects (OTO Open 2019, 2020; Frontiers Neurol 2022) (kahrilas2022retrogradeupperesophageal pages 4-6, yousef2024upperesophagealsphincter pages 8-12, xie2022casereporta pages 1-2).

2) Dysregulated pathways - Esophago‑UES relaxation reflex (EURR) is blunted/absent in R-CPD, while esophago‑UES contraction reflex (EUCR) and secondary peristalsis compensate; animal studies demonstrate differential activation by rapid (mucosal) vs slow (muscularis) distension, and that SLN afferents mediate CP inhibition during belch whereas vagal afferents are essential for belch initiation (AJP-GI 2012; AJP-GI 2019) (lang2012theroleof pages 1-1, lang2012theroleof pages 6-7, lang2019effectsofesophageal pages 18-23, lang2012theroleof pages 11-12). - Sensory modulation: esophageal acidification sensitizes EURR short-term but desensitizes both EURR and EUCR with prolonged exposure, highlighting plasticity that may modulate R-CPD phenotype (AJP-GI 2019) (lang2019effectsofesophageal pages 18-23). - Central/afferent modulation: GABA-B agonism reduces vagal afferent traffic and can block distension-induced UES responses, indicating GABAergic control over afferent gating (Szczesniak 2008) (szczesniak2008…andpathophysiological pages 88-94).

3) Affected cellular processes - Impaired neuromuscular inhibition of skeletal muscle (CP) during retrograde gas events; altered sensorimotor integration of vagal/SLN afferents with medullary nuclei coordinating UES relaxation and laryngeal closure; secondary peristalsis recruitment for gas clearance (kahrilas2022retrogradeupperesophageal pages 3-4, lang2012theroleof pages 11-12, lang2019effectsofesophageal pages 18-23).

Key Molecular Players

  • Genes/Proteins (evidence-based functional roles)
  • GABA-B receptor signaling (GABBR1/2; HGNC:4085/4086): pharmacologic activation (baclofen) dampens vagal afferent signaling and can inhibit distension-induced UES responses (szczesniak2008…andpathophysiological pages 88-94).
  • Mechanoreceptor apparatus of vagal afferents, notably intraganglionic laminar endings (IGLEs) in the muscularis, mediating EUCR/secondary peristalsis; rapidly adapting mucosal mechanoreceptors mediating belch/EURR (functional entities rather than single genes) (lang2012theroleof pages 6-7, lang2012theroleof pages 9-10).
  • Chemical Entities (CHEBI)
  • Botulinum toxin type A (CHEBI:3603): chemodenervation of CP restores belching; high real-world efficacy (kahrilas2022retrogradeupperesophageal pages 4-6, yousef2024upperesophagealsphincter pages 8-12, xie2022casereporta pages 1-2).
  • Baclofen (CHEBI:2299): GABA-B agonist that reduces vagal afferent traffic and transient reflex relaxations in upper gut physiology (szczesniak2008…andpathophysiological pages 88-94).
  • Cell Types (CL)
  • Cricopharyngeus skeletal muscle fibers (striated muscle cells) (kahrilas2022retrogradeupperesophageal pages 3-4, kahrilas2022retrogradeupperesophageal pages 1-3).
  • Vagal sensory neurons and SLN sensory fibers innervating esophageal mucosa/muscularis (lang2012theroleof pages 11-12, lang2012theroleof pages 6-7).
  • Brainstem medullary neurons coordinating reflexes (dorsal motor nucleus involvement described; central processing emphasized) (lang2012theroleof pages 11-12).
  • Anatomical Locations (UBERON)
  • Upper esophageal sphincter (UES) region and cricopharyngeus muscle of the inferior pharyngeal constrictor; proximal cervical esophagus; larynx/glottis (kahrilas2022retrogradeupperesophageal pages 3-4, kahrilas2022retrogradeupperesophageal pages 1-3, lang2012theroleof pages 6-7).

Biological Processes (GO annotation candidates)

  • Esophago‑upper esophageal sphincter relaxation reflex (part of reflex-mediated smooth/striated muscle relaxation) (kahrilas2022retrogradeupperesophageal pages 3-4, lang2019effectsofesophageal pages 18-23).
  • Reflex regulation of skeletal muscle contraction/relaxation (UE S/CP) during gas venting (kahrilas2022retrogradeupperesophageal pages 3-4, lang2012theroleof pages 11-12).
  • Mechanosensory transduction in esophageal mucosa/muscularis (vagal/SLN afferents; IGLEs) (lang2012theroleof pages 6-7, lang2012theroleof pages 9-10).
  • Secondary peristalsis and esophageal motility patterns (increased ineffective swallows; impaired bolus clearance) (yousef2024upperesophagealsphincter pages 8-12).
  • GABAergic modulation of vagal afferent signaling (szczesniak2008…andpathophysiological pages 88-94).

Cellular Components

  • Cricopharyngeus neuromuscular junctions and sarcomeric contractile apparatus (implied by CP hypertonia; generalized physiology contextualized to UES) (kahrilas2022retrogradeupperesophageal pages 1-3).
  • Esophageal mucosal mechanoreceptors and muscularis-layer IGLEs as afferent transducers (lang2012theroleof pages 6-7, lang2012theroleof pages 9-10).
  • Brainstem medullary nuclei (including dorsal motor nucleus) participating in reflex integration and output (lang2012theroleof pages 11-12).

Disease Progression

  • Initiating trigger: transient LES relaxation with gas reflux (or exogenous gas from carbonated drink) creates proximal esophageal pressurization (kahrilas2022retrogradeupperesophageal pages 3-4).
  • Physiologic bottleneck: UES/CP fails to exhibit complete reflex relaxation to retrograde gaseous distension (EURR impairment), despite normal swallow-related relaxation (kahrilas2022retrogradeupperesophageal pages 3-4, xie2022casereporta pages 1-2).
  • Compensatory patterns: secondary peristalsis and EUCR predominate; gas fails to vent, leading to repetitive gurgling and air entrapment (kahrilas2022retrogradeupperesophageal pages 1-3, kahrilas2022retrogradeupperesophageal pages 3-4).
  • Clinical manifestations: inability to belch, chest/neck gurgling, bloating/abdominal discomfort, chest pain, excessive flatulence, sometimes nausea/hiccups (kahrilas2022retrogradeupperesophageal pages 4-6, lechien2025etiologyclinicalpresentation pages 1-3).
  • Modifiers: Elevated basal UES pressure/length and ineffective esophageal motility may worsen severity; peripheral sensitization/desensitization (acid exposure) may shift reflex thresholds (yousef2024upperesophagealsphincter pages 8-12, lang2019effectsofesophageal pages 18-23).
  • Interventions and outcomes: CP botulinum toxin injection rapidly restores belching and reduces symptoms in >85–95% short term; many retain function beyond drug window, suggesting reflex reprogramming; a subset needs repeat injection or myotomy (yousef2024upperesophagealsphincter pages 8-12, kahrilas2022retrogradeupperesophageal pages 4-6, krekeler2024cricopharyngeusmuscledysfunction pages 4-6, lechien2025etiologyclinicalpresentation pages 1-3).

Phenotypic Manifestations (HPO)

  • Inability to belch (abelchia; cardinal feature) (kahrilas2022retrogradeupperesophageal pages 4-6, lechien2025etiologyclinicalpresentation pages 1-3).
  • Abdominal bloating (HP:0003270) (lechien2025etiologyclinicalpresentation pages 1-3, kahrilas2022retrogradeupperesophageal pages 4-6).
  • Chest pain/discomfort (HP:0100749) (lechien2025etiologyclinicalpresentation pages 1-3).
  • Flatulence (HP:0032276) (lechien2025etiologyclinicalpresentation pages 1-3, kahrilas2022retrogradeupperesophageal pages 4-6).
  • Nausea (HP:0002018) (lechien2025etiologyclinicalpresentation pages 1-3).
  • Hiccups (Singultus; HP:0025095) (kahrilas2022retrogradeupperesophageal pages 1-3).
  • Audible gurgling from chest/neck (symptom noted in series) (kahrilas2022retrogradeupperesophageal pages 4-6, kahrilas2022retrogradeupperesophageal pages 1-3).

Evidence items with PMIDs/DOIs, URLs, and dates

  • Kahrilas PJ. Retrograde upper esophageal sphincter function… and dysfunction. Neurogastroenterology & Motility. Feb 2022. DOI:10.1111/nmo.14328; URL: https://doi.org/10.1111/nmo.14328 (Mechanism and HRIM provocation; therapeutic implications) (kahrilas2022retrogradeupperesophageal pages 1-3, kahrilas2022retrogradeupperesophageal pages 4-6).
  • Yousef A, et al. Upper Esophageal Sphincter and Esophageal Motility Pathology on Manometry in R-CPD. Otolaryngology–Head & Neck Surgery. Apr 2024. DOI:10.1002/ohn.735; URL: https://doi.org/10.1002/ohn.735 (Case-control HRIM; elevated UES pressure/length; dysmotility) (yousef2024upperesophagealsphincter pages 8-12).
  • Dorfman L, et al. Pediatric R-CPD diagnosed by HRIM. Journal of Pediatric Gastroenterology and Nutrition. Mar 2024. DOI:10.1002/jpn3.12193; URL: https://doi.org/10.1002/jpn3.12193 (Selective retrograde UES failure; CP botulinum response) (xie2022casereporta pages 1-2).
  • Bastian RW, Smithson ML. Inability to Belch… Diagnosis and Treatment. OTO Open. Mar 2019. DOI:10.1177/2473974x19834553; URL: https://doi.org/10.1177/2473974x19834553 (Syndromic definition; BTX proof-of-concept) (kahrilas2022retrogradeupperesophageal pages 4-6).
  • Hoesli RC, Wingo ML, Bastian RW. Long-term Efficacy of Botulinum Toxin for R-CPD. OTO Open. Apr 2020. DOI:10.1177/2473974x20938342; URL: https://doi.org/10.1177/2473974x20938342 (Large outcomes series) (yousef2024upperesophagealsphincter pages 8-12, krekeler2024cricopharyngeusmuscledysfunction pages 4-6).
  • Xie M, Wen H, Dou Z. Case report: Novel treatment for R-CPD. Frontiers in Neurology. Dec 2022. DOI:10.3389/fneur.2022.1005655; URL: https://doi.org/10.3389/fneur.2022.1005655 (HRM residual pressure normalized post-BTX) (xie2022casereporta pages 1-2).
  • Krekeler BN, Howell RJ. Cricopharyngeus muscle dysfunction: review. Eur Arch Otorhinolaryngol. May 2024. DOI:10.1007/s00405-024-08644-7; URL: https://doi.org/10.1007/s00405-024-08644-7 (Diagnostic considerations; HRPM-I thresholds; BTX) (krekeler2024cricopharyngeusmuscledysfunction pages 4-6).
  • Lang IM, Medda BK, Jadcherla S, Shaker R. Role of SLN in esophageal reflexes. Am J Physiol Gastrointest Liver Physiol. Jun 2012. DOI:10.1152/ajpgi.00007.2012; URL: https://doi.org/10.1152/ajpgi.00007.2012 (Belch subreflexes; SLN/vagal roles; CP inhibition) (lang2012theroleof pages 11-12, lang2012theroleof pages 1-1, lang2012theroleof pages 6-7, lang2012theroleof pages 9-10).
  • Lang IM, Medda BK, Shaker R. Effects of esophageal acidification on UES reflexes. Am J Physiol Gastrointest Liver Physiol. Jan 2019. DOI:10.1152/ajpgi.00292.2018; URL: https://doi.org/10.1152/ajpgi.00292.2018 (EURR/EUCR modulation by acid; reflex plasticity) (lang2019effectsofesophageal pages 18-23).
  • Szczesniak MM. Esophageal afferents and reflexes (review). 2008 (vagal mechanoreceptors; GABA-B modulation of afferent drive and UES reflexes) (szczesniak2008…andpathophysiological pages 58-61, szczesniak2008…andpathophysiological pages 88-94).

Gene/protein annotations with ontology terms

  • GABBR1 (HGNC:4085) and GABBR2 (HGNC:4086): GABA-B receptor subunits; process: modulation of vagal afferent neurotransmission controlling reflex UES relaxation (GO:0051932—GABAergic synaptic transmission; GO:0007216—G-protein coupled glutamate receptor signaling pathway as related family); evidence: GABA-B agonism blocks distension-induced UES responses (szczesniak2008…andpathophysiological pages 88-94).
  • Structural/functional units: intraganglionic laminar endings (IGLEs) of vagal afferents (cellular component: peripheral nervous system sensory ending; process: mechanosensory transduction; GO:0050974) (lang2012theroleof pages 6-7, lang2012theroleof pages 9-10).

Cell type involvement (CL)

  • CL:0000187 skeletal muscle cell—cricopharyngeus fibers (effector of UES tone/relaxation) (kahrilas2022retrogradeupperesophageal pages 1-3).
  • CL:0000101 sensory neuron—vagal and SLN afferents mediating EURR/EUCR (lang2012theroleof pages 11-12, lang2012theroleof pages 6-7).

Anatomical locations (UBERON)

  • UBERON:0001041 upper esophageal sphincter; UBERON:0015205 cricopharyngeus muscle; UBERON:0001043 cervical esophagus; UBERON:0001738 larynx; UBERON:0001638 glottis (kahrilas2022retrogradeupperesophageal pages 3-4, lang2012theroleof pages 6-7, kahrilas2022retrogradeupperesophageal pages 1-3).

Chemical entities (CHEBI)

  • CHEBI:3603 botulinum toxin type A—therapeutic chemodenervation of CP (kahrilas2022retrogradeupperesophageal pages 4-6, yousef2024upperesophagealsphincter pages 8-12, xie2022casereporta pages 1-2).
  • CHEBI:2299 baclofen—GABA-B agonist modulating afferent signaling and UES reflex responses (szczesniak2008…andpathophysiological pages 88-94).

Biological process and cellular component mapping (GO)

  • GO:0003008 system process (reflex), GO:0006936 muscle contraction/relaxation, GO:0050954 sensory perception of mechanical stimulus, GO:0007610 behavior (belch reflex as patterned motor output), GO:0005886 plasma membrane (GABA-B receptors), GO:0045202 synapse (afferent modulation), GO:0045211 postsynaptic membrane (kahrilas2022retrogradeupperesophageal pages 3-4, szczesniak2008…andpathophysiological pages 88-94, lang2012theroleof pages 6-7, lang2019effectsofesophageal pages 18-23).

Direct quotes supporting key statements

  • “Rapid esophageal distension reliably triggers belching… SLN transection blocked inhibition of cricopharyngeus EMG during the belch, whereas vagotomy abolished all belch-related responses.” (Am J Physiol Gastrointest Liver Physiol, 2012; https://doi.org/10.1152/ajpgi.00007.2012) (lang2012theroleof pages 6-7, lang2012theroleof pages 1-1).
  • “RCPD is associated with a longer UES, elevated UES basal pressures, and an increased incidence of ineffective esophageal motility.” (Otolaryngology–Head & Neck Surgery, 2024; https://doi.org/10.1002/ohn.735) (yousef2024upperesophagealsphincter pages 8-12).
  • “All 51 patients achieved ability to belch and relief of associated symptoms… the majority seem to have ‘retrained’ the ability to belch on a potentially ‘permanent’ basis.” (OTO Open, 2019; https://doi.org/10.1177/2473974x19834553) (kahrilas2022retrogradeupperesophageal pages 4-6).

Summary for knowledge base

R-CPD is a reflex-specific neuromuscular disorder of the UES in which failure of cricopharyngeus relaxation during retrograde gaseous distension leads to air entrapment and cardinal symptoms. HRIM with provocation provides objective evidence; botulinum toxin to CP is a highly effective diagnostic-therapeutic intervention. Mechanistically, vagal and SLN afferents, mucosal vs muscular mechanoreceptors, and central medullary circuits coordinate belch subreflexes; afferent gating (e.g., GABA-B) and peripheral sensitization (acid) modulate reflex thresholds. Coexisting esophageal motility abnormalities and elevated UES basal pressure/length may influence phenotype and treatment durability (kahrilas2022retrogradeupperesophageal pages 1-3, yousef2024upperesophagealsphincter pages 8-12, kahrilas2022retrogradeupperesophageal pages 4-6, xie2022casereporta pages 1-2, krekeler2024cricopharyngeusmuscledysfunction pages 4-6, lechien2025etiologyclinicalpresentation pages 1-3, lang2012theroleof pages 6-7, lang2019effectsofesophageal pages 18-23).

References

  1. (kahrilas2022retrogradeupperesophageal pages 1-3): Peter J. Kahrilas. Retrograde upper esophageal sphincter function… and dysfunction. Neurogastroenterology & Motility, Feb 2022. URL: https://doi.org/10.1111/nmo.14328, doi:10.1111/nmo.14328. This article has 31 citations and is from a peer-reviewed journal.

  2. (kahrilas2022retrogradeupperesophageal pages 4-6): Peter J. Kahrilas. Retrograde upper esophageal sphincter function… and dysfunction. Neurogastroenterology & Motility, Feb 2022. URL: https://doi.org/10.1111/nmo.14328, doi:10.1111/nmo.14328. This article has 31 citations and is from a peer-reviewed journal.

  3. (yousef2024upperesophagealsphincter pages 8-12): Andrew Yousef, Amanda Krause, Rena Yadlapati, Priya Sharma, and Philip A. Weissbrod. Upper esophageal sphincter and esophageal motility pathology on manometry in retrograde cricopharyngeal dysfunction. Otolaryngology–head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 171:478-485, Apr 2024. URL: https://doi.org/10.1002/ohn.735, doi:10.1002/ohn.735. This article has 15 citations.

  4. (xie2022casereporta pages 1-2): Mengshu Xie, Hongmei Wen, and Zulin Dou. Case report: a case of novel treatment for retrograde cricopharyngeal dysfunction. Frontiers in Neurology, Dec 2022. URL: https://doi.org/10.3389/fneur.2022.1005655, doi:10.3389/fneur.2022.1005655. This article has 12 citations and is from a peer-reviewed journal.

  5. (krekeler2024cricopharyngeusmuscledysfunction pages 4-6): Brittany N. Krekeler and Rebecca J. Howell. Cricopharyngeus muscle dysfunction: a poorly defined disorder from diagnosis to treatment. European Archives of Oto-Rhino-Laryngology, 281:4519-4527, May 2024. URL: https://doi.org/10.1007/s00405-024-08644-7, doi:10.1007/s00405-024-08644-7. This article has 3 citations and is from a peer-reviewed journal.

  6. (kahrilas2022retrogradeupperesophageal pages 3-4): Peter J. Kahrilas. Retrograde upper esophageal sphincter function… and dysfunction. Neurogastroenterology & Motility, Feb 2022. URL: https://doi.org/10.1111/nmo.14328, doi:10.1111/nmo.14328. This article has 31 citations and is from a peer-reviewed journal.

  7. (lechien2025etiologyclinicalpresentation pages 1-3): Jérôme R. Lechien, Marie Mailly, Stephane Hans, and Lee M. Akst. Etiology, clinical presentation, and management of retrograde cricopharyngeus dysfunction: a systematic review. Journal of Otolaryngology - Head & Neck Surgery, May 2025. URL: https://doi.org/10.1177/19160216251329012, doi:10.1177/19160216251329012. This article has 6 citations.

  8. (lang2012theroleof pages 11-12): I. M. Lang, B. K. Medda, S. Jadcherla, and R. Shaker. The role of the superior laryngeal nerve in esophageal reflexes. American journal of physiology. Gastrointestinal and liver physiology, 302 12:G1445-57, Jun 2012. URL: https://doi.org/10.1152/ajpgi.00007.2012, doi:10.1152/ajpgi.00007.2012. This article has 41 citations.

  9. (lang2012theroleof pages 1-1): I. M. Lang, B. K. Medda, S. Jadcherla, and R. Shaker. The role of the superior laryngeal nerve in esophageal reflexes. American journal of physiology. Gastrointestinal and liver physiology, 302 12:G1445-57, Jun 2012. URL: https://doi.org/10.1152/ajpgi.00007.2012, doi:10.1152/ajpgi.00007.2012. This article has 41 citations.

  10. (lang2019effectsofesophageal pages 18-23): Ivan M. Lang, Bidyut K. Medda, and Reza Shaker. Effects of esophageal acidification on esophageal reflexes controlling the upper esophageal sphincter. American journal of physiology. Gastrointestinal and liver physiology, 316 1:G45-G54, Jan 2019. URL: https://doi.org/10.1152/ajpgi.00292.2018, doi:10.1152/ajpgi.00292.2018. This article has 19 citations.

  11. (szczesniak2008…andpathophysiological pages 58-61): MM Szczesniak. … and pathophysiological modulation of oesophageal afferent pathways: implications for oesophago-pharyngeal reflexes, regurgitation and symptom perception. Unknown journal, 2008.

  12. (szczesniak2008…andpathophysiological pages 88-94): MM Szczesniak. … and pathophysiological modulation of oesophageal afferent pathways: implications for oesophago-pharyngeal reflexes, regurgitation and symptom perception. Unknown journal, 2008.

  13. (lang2012theroleof pages 6-7): I. M. Lang, B. K. Medda, S. Jadcherla, and R. Shaker. The role of the superior laryngeal nerve in esophageal reflexes. American journal of physiology. Gastrointestinal and liver physiology, 302 12:G1445-57, Jun 2012. URL: https://doi.org/10.1152/ajpgi.00007.2012, doi:10.1152/ajpgi.00007.2012. This article has 41 citations.

  14. (lang2012theroleof pages 9-10): I. M. Lang, B. K. Medda, S. Jadcherla, and R. Shaker. The role of the superior laryngeal nerve in esophageal reflexes. American journal of physiology. Gastrointestinal and liver physiology, 302 12:G1445-57, Jun 2012. URL: https://doi.org/10.1152/ajpgi.00007.2012, doi:10.1152/ajpgi.00007.2012. This article has 41 citations.